Dr. Phil Sinclair is a seasoned medical and clinical executive with over 25 years of experience in the medical device, pharmaceutical, and biotechnology industries. He is the Vice President of Global Medical Affairs & Clinical Development at Boston Scientific, leading clinical evidence initiatives in Interventional Oncology and Embolization. Phil collaborates with global experts, healthcare professionals, and clinical investigators to improve patient care through evidence-based approaches. He has served on numerous scientific and strategic advisory boards across corporate, medical society, and government levels and has a strong track record of driving impactful programs across the product development lifecycle. He holds a PhD in Molecular Toxicology.
Phil Sinclair, PhD
Vice President, Global Medical Affairs and Clinical Development (Interventional Oncology & Embolization) | Boston Scientific
